anti-Diphtheria toxin antibody product blogThe Diphtheria toxin dt (Catalog #MBS5305972) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Mouse monoclonal Diphtheria toxin antibody reacts with Reacts with the epitope exposed on free A-subunit and on whole Diphtheria toxin molecule. Does not react with free B-subunit of Diphtheria toxin. and may cross-react with other species as described in the data sheet. MyBioSource\'s Diphtheria toxin can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunoassays. Researchers should empirically determine the suitability of the Diphtheria toxin dt for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The Diphtheria toxin dt product has the following accession number(s) (GI #579179) (NCBI Accession #CAA24778.1) (Uniprot Accession #P00587). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Diphtheria toxoid. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Diphtheria toxin are readily searchable from our website. Different antibodies against the same target such as Diphtheria toxin may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.